Commtouch buys US co's antivirus unit bi2280538 Commtouch bought the assets, products, licenses, and operations of the Command anti division of Authentium for $4.6 million

Singapore Air CEO May Step Down After Doubling Stock bi2280538 Singapore Airlines Ltd. Chief Executive Officer Chew Choon Seng, who took a pay cut maintaining the carriers wine budget during the recession, samples economy-class meals every month to make sure they meet standards

Cyplasin Biomedical Ltd Secures $10 Million Equity Credit Line Financing bi2280538 Cyplasin Biomedical a product-oriented, specialty pharmaceutical company focused on developing products for the multi-billion dollar hepatitis C market. The Company pleased to announce that has secured US$10 Million financing under an equity line of credit Tangiers Investors, LP to fund the Company's operations and product development programs

Response Biomedical Corporation Shareholders Approve $8 Million Private Place bi2280538 VANCOUVER, British Columbia----Response Biomedical Corporation announced that at the Companys Special General Shareholders Meeting held today Vancouver, shareholders approved the private placement of an aggregate of 13,333,333 common shares , at a price of Cdn. $0.60 per Offered Share, to Caduceus Private Investments III, LP, OrbiMed Associates III, LP and Caduceus Asia Partners, LP for ..

Advance on AIDS Raises Questions as Well as Joy bi2280538 Experts are pondering issues raised after a trial found that a vaginal gel could help women avoid infection

Singapore Air Looks for New CEO bi2280538 Singapore Airlines Ltd., the worlds second-largest carrier by market value, said considering several candidates to become chief executive officer as Chew Choon Seng signaled that he step down

NewsLeecher Inches Closer to Version 4.0 bi2280538 Leech that binary..

Birthday Mail/Kokurri-san Double Feature bi2280538 When the living attract the attention of the dead the living are at an incredible disadvantage..

Genzyme Said to Rebuff Sanofi-Aventis Buyout Approach bi2280538 Genzyme Corp., the worlds largest maker of drugs for rare genetic diseases, rebuffed Sanofi- Aventis SAs takeover approach last week, two people knowledge of the matter said today

Genzyme Said to Rebuff Sanofi-Aventis Takeover Approach; Genzyme Advances bi2280538 Genzyme Corp. , the largest maker of medicines for genetic diseases, rebuffed Sanofi-Aventis SA s takeover approach, said two people knowledge of the matter

Singapore Air CEO May Step Down After Doubling Stock bi2280538 Singapore Airlines Ltd. Chief Executive Officer Chew Choon Seng, who took a pay cut maintaining the carriers wine budget during the recession, samples economy-class meals every month to make sure they meet standards

Cyplasin Biomedical Ltd Secures $10 Million Equity Credit Line Financing bi2280538 Cyplasin Biomedical a product-oriented, specialty pharmaceutical company focused on developing products for the multi-billion dollar hepatitis C market. The Company pleased to announce that has secured US$10 Million financing under an equity line of credit Tangiers Investors, LP to fund the Company's operations and product development programs

Lightning Protectors - Home